A randomized phase II study comparing capecitabine alone with capecitabine and oral cyclophosphamide in patients with advanced breast cancer-cyclox II. [electronic resource]
Producer: 20131211Description: 1828-1834 p. digitalISSN:- 1569-8041
- Administration, Oral
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Breast Neoplasms -- drug therapy
- Capecitabine
- Cyclophosphamide -- administration & dosage
- Deoxycytidine -- administration & dosage
- Disease-Free Survival
- Female
- Fluorouracil -- administration & dosage
- Humans
- Liver Neoplasms -- drug therapy
- Lymphatic Metastasis
- Middle Aged
- Neutropenia -- chemically induced
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase II; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.